Speaker illustration

Doctor Meena Rao

Duke Clinical Research Institute, Durham (United States of America)

Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: New trends in antithrombotic therapy for atrial fibrillation

Thumbnail

This platform is supported by

logo Novo Nordisk